November 29, 2016 - By olga
In an analyst report sent to investors and clients on Tuesday morning, Scapa Group PLC (LON:SCPA) stock had its Add Rating reaffirmed by analysts at Numis. They currently have a GBX 340.00 target price per share on company. Numis’s target suggests a potential upside of 9.02% from the company’s last stock close price.
Out of 4 analysts covering Scapa Group (LON:SCPA), 3 rate it a “Buy”, 0 “Sell”, while 1 “Hold”. This means 75% are positive. GBX 340 is the highest target while GBX 210 is the lowest. The GBX 317 average target is 1.93% above today’s (GBX 311) stock price. Scapa Group has been the topic of 23 analyst reports since July 21, 2015 according to StockzIntelligence Inc. The company was downgraded on Tuesday, July 19 by Numis Securities. As per Tuesday, October 13, the company rating was maintained by N+1 Singer. The stock of Scapa Group plc (LON:SCPA) earned “Buy” rating by Berenberg on Wednesday, May 25. Cantor Fitzgerald maintained Scapa Group plc (LON:SCPA) rating on Thursday, June 2. Cantor Fitzgerald has “Hold” rating and GBX 285 price target. Numis Securities maintained the shares of SCPA in a report on Tuesday, May 24 with “Add” rating. The firm has “Hold” rating by Numis Securities given on Wednesday, October 12. The company was upgraded on Tuesday, October 13 by Numis Securities. Cantor Fitzgerald maintained Scapa Group plc (LON:SCPA) rating on Thursday, April 14. Cantor Fitzgerald has “Hold” rating and GBX 235 price target. Numis Securities maintained Scapa Group plc (LON:SCPA) rating on Thursday, April 14. Numis Securities has “Add” rating and GBX 255 price target. As per Tuesday, April 19, the company rating was maintained by Berenberg.
About 257,593 shares traded hands. Scapa Group plc (LON:SCPA) has risen 27.82% since April 29, 2016 and is uptrending. It has outperformed by 22.56% the S&P500.
Scapa Group Plc is a holding company for a group of companies operating in the manufacture of bonding products and adhesive components for applications in the healthcare and industrial markets. The company has a market cap of 470.89 million GBP. The Firm operates through two divisions: Industrial and Healthcare. It has a 46.07 P/E ratio. The Company’s Industrial segment makes and delivers a portfolio of adhesive bonding solutions and applications.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.